World AMR Awareness Week (WAAW) 2025
Public Alert No. 032/2025 – Alert on the Discontinuation of the Production of Penicillin-Based Moiety by Miraflash
The National Agency for Food and Drug Administration and Control (NAFDAC) is informing the public about Miraflash Nigeria Limited’s decision to cease production of its penicillin-based products. This decision, taken by Miraflash Nigeria Limited, has nothing to do with the quality or safety of the penicillin-based products produced within their facility, but rather to avoid […]
Public Alert No. 038/2025 – Prohibition of Use and Sale of Bledine Infant Cereals by Chadian Authorities
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public of a report received regarding the prohibition of the use, distribution and sale of Bledine Infant Cereals, manufactured by Danone Group, a French multinational food and beverage company, by the Chadian authorities. The report states that the ban was imposed […]
Public Alert No. 37/2025 – Alert on the Report of Substandard and Falsified (SF) BETACLOX found in Nigeria
The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting the public about a suspected substandard and falsified (SF) pharmaceutical product identified within the drug supply chain. The product in question, BETACLOX (a combination of ampicillin and cloxacillin), contains fraudulent registration details and comes from an unverified source, posing significant risks to […]
Public Alert No. 36/2025 – WHO Alert on 3 Substandard (contaminated) oral liquid medicines identified in India
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying Healthcare providers and the public of three substandard (contaminated) oral liquid medicines identified in India and reported to WHO on 8 October 2025. The contaminated oral liquid medicines have been identified to be specific batches of COLDRIF, Respifresh TR, and ReLife, manufactured […]
Public Alert No. 35/2025 – Substandard batches of Annmox (Amoxicillin suspensions 125mg/5ml) and Jawamox (Amoxicillin suspension 125mg/5ml) manufactured by Jawa International Ltd due to low Active Pharmaceutical Ingredient (API) content
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public about the mop up of batches of confirmed substandard Annmox (Batch 360M) and Jawamox (Batch 4231M & 4290M) Suspensions. The products failed laboratory analysis due to low Active Pharmaceutical Ingredient (API) content. The company has been directed to recall the failed […]
Public Alert No. 34/2025 –Substandard Astamocil (Amoxicillin Suspension 125mg/5ml), Batch No. 826024, and Astamentin (Amoxicillin/Clavulanic Acid Suspension), Batch Nos: 0503024 & 0501724, manufactured by Sam-Ace Ltd in Nigeria
The National Agency for Food and Drug Administration and Control (NAFDAC) is notifying the public about the recall of two products: Astamocil (Amoxicillin Suspension 125mg/5ml), Batch 826024, and Astamentin (Amoxicillin/Clavulanic Acid Suspension 228.5 mg), Batches 0503024 and 0501724, manufactured by Sam-Ace Ltd in Nigeria. The products were discovered by the Agency’s Post Marketing Surveillance Directorate […]
Public Alert No. 033/2025 – Alert on the Sale of Counterfeit Cialis Tablet 20mg in Nigeria
The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting the public about the distribution and sale of counterfeit Cialis 20mg tablets in Nigeria. Information received from the Marketing Authorization Holder (MAH) shows that the counterfeit version was discovered during a routine market surveillance in Abuja. It was reported that the counterfeit […]
Public Alert No. 032/2025 – Alert on the Discontinuation of the Production of Penicillin-Based Moiety by Miraflash
The National Agency for Food and Drug Administration and Control (NAFDAC) is notifying the public of the decision to discontinue the production of penicillin-based products by Miraflash Nigeria Limited. This decision is taken as a corrective measure and closure of a critical observation made during a GMP inspection conducted in the company by a team […]
Public Alert No. 031/2025 – Alert on the Presence of an Unauthorized/ Unregistered Darzalex (Daratumumab) 1800mg/15ml vial SC Injection in Nigeria
The National Agency for Food and Drugs Administration and Control (NAFDAC) is alerting the public on the sale of an unauthorized and unregistered brand of Daratumumab formulation in Nigeria. An internal investigation conducted by Johnson & Johnson revealed that there are two different packaging designs for their Daratumumab product. One design is intended for the […]
